Literature DB >> 19557530

Functional blocking of specific integrins inhibit colonic cancer migration.

John H Robertson1, Shi Yu Yang, Marc C Winslet, Alexander M Seifalian.   

Abstract

For more effective oncological management of disseminated colorectal cancer, therapies must be devised that target the different individual stages of metastasis development. Recent work showed that integrin subunits alpha2, alpha6 and beta4 are involved in the colorectal cancer cell extravasation process. By means of Immunocytochemistry and Western blotting, it was shown that all three integrins are expressed not only in human colorectal cancer cells (HT29) but also in rat colonic cancer cells (DHDK12). Using in vivo models and intravital video microscopy techniques, it was shown that functional blocking of these integrin subunits by specific antibodies produced a significant reduction in cancer cell extravasation and migration. In conclusion, integrin subunits alpha2, alpha6 and beta4 are expressed in unrelated colorectal cancer cell strains and appear to play a key role in cancer cell migration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557530     DOI: 10.1007/s10585-009-9276-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  44 in total

1.  Estimating the world cancer burden: Globocan 2000.

Authors:  D M Parkin; F Bray; J Ferlay; P Pisani
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

2.  Anti-beta4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP-2 expression.

Authors:  N Daemi; N Thomasset; J C Lissitzky; J Dumortier; M F Jacquier; C Pourreyron; P Rousselle; J A Chayvialle; L Remy
Journal:  Int J Cancer       Date:  2000-03-15       Impact factor: 7.396

3.  Adjuvant therapy for colon cancer--the pace quickens.

Authors:  Carmen Allegra; Daniel J Sargent
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

Review 4.  Integrins: molecular targets in cancer therapy.

Authors:  Gordon C Tucker
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

5.  Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids.

Authors:  Andreas Enns; Peter Gassmann; Kerstin Schlüter; Timo Korb; Hans-Ullrich Spiegel; Norbert Senninger; Jörg Haier
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

6.  Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver.

Authors:  Olaf R F Mook; Jan Van Marle; Heleen Vreeling-Sindelárová; Remmet Jonges; Wilma M Frederiks; Cornelis J F Van Noorden
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

Review 7.  Integrins: a method of early intervention in the treatment of colorectal liver metastases.

Authors:  John H Robertson; Arthur M Iga; Kevin M Sales; Marc C Winslet; Alexander M Seifalian
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 8.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

9.  Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.

Authors:  S Koop; I C MacDonald; K Luzzi; E E Schmidt; V L Morris; M Grattan; R Khokha; A F Chambers; A C Groom
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

10.  Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration.

Authors:  Thomas Manes; Duo-Qi Zheng; Simona Tognin; Amy S Woodard; Pier Carlo Marchisio; Lucia R Languino
Journal:  J Cell Biol       Date:  2003-05-26       Impact factor: 10.539

View more
  9 in total

Review 1.  HLA class I: an unexpected role in integrin β4 signaling in endothelial cells.

Authors:  Xiaohai Zhang; Elaine F Reed
Journal:  Hum Immunol       Date:  2012-07-10       Impact factor: 2.850

2.  Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).

Authors:  Feng Jiao; Ziliang Jin; Lei Wang; Liwei Wang
Journal:  Biomed Rep       Date:  2013-08-20

3.  Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.

Authors:  Eng-Zhuan Ban; Munn-Sann Lye; Pei Pei Chong; Yoke-Yeow Yap; Siew Ying Crystale Lim; Hejar Abdul Rahman
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

4.  CDX2 expression and perioperative patient serum affects the adhesion properties of cultured colon cancer cells.

Authors:  Johanne Davidsen; Stine Bull Jessen; Sara Kehlet Watt; Sylvester Larsen; Katja Dahlgaard; Tove Kirkegaard; Ismail Gögenur; Jesper T Troelsen
Journal:  BMC Cancer       Date:  2020-05-14       Impact factor: 4.430

5.  Association of hOGG1 Ser326Cys, ITGA2 C807T, TNF-A -308G>A and XPD Lys751Gln polymorphisms with the survival of Malaysian NPC patients.

Authors:  Eng-Zhuan Ban; Munn-Sann Lye; Pei Pei Chong; Yoke-Yeow Yap; Siew Ying Crystale Lim; Hejar Abdul Rahman
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

Review 6.  Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets.

Authors:  Christopher S Stipp
Journal:  Expert Rev Mol Med       Date:  2010-01-18       Impact factor: 5.600

7.  Evaluation of Extracellular Matrix Composition to Improve Breast Cancer Modeling.

Authors:  Charles Ethan Byrne; Jean-Baptiste Decombe; Grace C Bingham; Jordan Remont; Lindsay G Miller; Layah Khalif; Connor T King; Katie Hamel; Bruce A Bunnell; Matthew E Burow; Elizabeth C Martin
Journal:  Tissue Eng Part A       Date:  2021-04       Impact factor: 3.845

8.  A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6.

Authors:  Serena Marchiò; Marco Soster; Sabrina Cardaci; Andrea Muratore; Alice Bartolini; Vanessa Barone; Dario Ribero; Maria Monti; Paola Bovino; Jessica Sun; Raffaella Giavazzi; Sofia Asioli; Paola Cassoni; Lorenzo Capussotti; Piero Pucci; Antonella Bugatti; Marco Rusnati; Renata Pasqualini; Wadih Arap; Federico Bussolino
Journal:  EMBO Mol Med       Date:  2012-10-16       Impact factor: 12.137

9.  Epigenetic silencing of ITGA2 by MiR-373 promotes cell migration in breast cancer.

Authors:  Wen Ding; Xiao-Lu Fan; Xuan Xu; Jin-Zhou Huang; Song-Hui Xu; Qian Geng; Rong Li; De Chen; Guang-Rong Yan
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.